Roei Singolda

Roei Singolda

Auto-generated profile, based on publicly available information

Roei Singolda

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2020 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
RSRoei Singolda
Roei Singolda
GBGal Bracha
Gal Bracha
TZTariq Zoabi
Tariq Zoabi
AZArik Zaretski
Arik Zaretski
AIAmir Inbal
Amir Inbal
EAEhud Arad
Ehud Arad

3 February 2025 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
GSGon Shoham
Gon Shoham
TZTom Zuckerman
Tom Zuckerman
EFEhud Fliss
Ehud Fliss
OGOrel Govrin
Orel Govrin
AZArik Zaretski
Arik Zaretski
YBYoav Barnea
Yoav Barnea
Background: Breast reduction is a common procedure with growing rates in the United States of America, aimed at alleviating the physical and psychological burdens of macromastia. Despite high success rates, it carries a risk of complications, with incidence rates ranging from 6.2% to 43%. Objectives: The authors developed a machine learning model using gradient-boosting decision trees to predict severe breast reduction complications up to 30 days following surgery requiring inpatient care. Methods: This retrospective study included 322 cases of breast reduction surgery performed at the Tel Aviv Medical Center from 2017 to 2024. Model performance was evaluated using 5-fold cross-validation, and key metrics such as area under the receiver operating characteristic curve, accuracy, sensitivity, and specificity were reported. An interpretability tool was also created to visualize complication risks based on clinical features. Results: Severe complications occurred in 7.4% of cases. Key predictive factors included specimen weight, SN-N distance, and liposuction volume. The model achieved an area under the receiver operating characteristic curve (AUC-ROC) of 0.83, with an accuracy of 0.93 and a negative predictive value (NPV) of 0.95. The interpretability tool clearly visualized complication risks, aiding preoperative counseling. Conclusions: This is the first study to use artificial intelligence (AI) to predict severe complications in breast reduction surgery. In this study, the AI model, with an AUC-ROC of 0.83 and NPV of 0.95, offers a reliable tool for surgical planning and patient education. Further validation across diverse populations is recommended to confirm its clinical utility. Level of Evidence: 4 (Risk):

18 October 2022 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
PDF file
DADana Adelson
Dana Adelson
RSRoei Singolda
Roei Singolda
OHOriana Haran
Oriana Haran
EMEhab Madah
Ehab Madah
DBDaphna Barsuk
Daphna Barsuk
YBYoav Barnea
Yoav Barnea
Background: Round nano-surface Ergonomix (Motiva, Establishment Labs; Alajuela, Costa Rica) implants were developed to address concerns regarding capsular contracture and textured anatomical breasts implants. Objectives: The authors describe their early experience with Ergonomix implants in breast reconstruction. Methods: The authors retrospectively reviewed the charts of 212 patients (321 breasts) who underwent breast reconstruction employing round nano-surface Ergonomix implants between June 2017 and December 2020. Patients were followed for at least 12 months postoperatively. Demographics, surgical data, and postoperative surgical outcomes were recorded. Postoperative physical well-being and satisfaction with the breasts and implant were evaluated with Breast-Q questionnaires. Results: Of 211 patients, 75.4% had surgery due to cancer, and 24.6% underwent prophylactic surgery. Major complications occurred in 21 breasts (6.5%), of which 20 underwent revision operations. Reconstruction failed in 1 case (0.3%). Eleven breasts (3.4%) had minor complications. Immediate breast reconstruction, irradiated breasts, and smokers had higher rates of complications (P = 0.009, 0.02, 0.022, respectively). Rippling was more common in the pre-pectoral implant plane compared with sub-pectoral reconstruction (9% vs 1.2%, P = 0.001). Capsular contracture rate was 0.9% and occurred only in irradiated breasts. Implant malposition (inferiorly and laterally) occurred in 6.5% of the breasts, with no association between implant malposition and implant plane. Early follow-up demonstrated high patient satisfaction with the implant and breasts, and high scores in terms of patients’ physical well-being. Conclusions: Breast reconstruction employing the round nano-surface Ergonomix implant yielded low complication rates and high patient satisfaction. The transition from macro-textured to nano-surface implants has operative implications requiring a learning curve and surgical adjustments. Level of Evidence: 4:

9 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GSGon Shoham
Gon Shoham
OHOriana Haran
Oriana Haran
RSRoei Singolda
Roei Singolda
EMEhab Madah
Ehab Madah
AMAda Magen
Ada Magen
YBYoav Barnea
Yoav Barnea
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-cell lymphoma detected in association with textured implants. It presents as a fluid accumulation around the implant, usually years after the implantation. We present our experience in diagnosing and treating four patients with BIA-ALCL, each widely differing from the other. Data on patients’ surgical history, relevant medical information, and findings on pathological slides were retrieved from their medical charts and retrospectively reviewed. Each of the four patients was diagnosed with BIA-ALCL, one after breast augmentation, one after breast reconstruction with an implant, one after breast reconstruction with a latissimus dorsi flap and implant, and the fourth after the removal of breast implants. The cases were presented to a multidisciplinary team and subsequently underwent surgery. All four are currently free of tumors, as established by a negative follow-up via positron emission tomography-computed tomography. Although the incidence of BIA-ALCL is rare, these cases emphasize the need to rule out the diagnosis of BIA-ALCL in patients with textured implants or a history of implanted textured devices who present with symptoms such as late seroma or peri-implant mass. This pathology is typically indolent and slow-growing and heightened awareness for an early diagnosis could lead to quicker intervention and enhanced patient management.

2 June 2022 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
RSRoei Singolda
Roei Singolda
GBGal Bracha
Gal Bracha
TZTariq Zoabi
Tariq Zoabi
AZArik Zaretski
Arik Zaretski
AIAmir Inbal
Amir Inbal
EAEhud Arad
Ehud Arad

11 May 2026 in European Journal of Plastic Surgery
Verified
Journal Article
Open access
PDF file
OBOri Berger
Ori Berger
MDMichal Dekel
Michal Dekel
LPLior Prozan
Lior Prozan
MLMoshe Lachiani
Moshe Lachiani
EMEhab Madah
Ehab Madah
RSRoei Singolda
Roei Singolda